A population-based analysis of patterns of care in patients with high-risk non-muscle-invasive bladder cancer from Alberta, Canada Article Swipe
Geoffrey Gotto
,
Nimira Alimohamed
,
Girish S. Kulkarni
,
Peter C. Black
,
Wassim Kassouf
,
Andrea Kokorovic
,
Bernhard J. Eigl
,
Normand Blais
,
Aly‐Khan A. Lalani
,
Winson Y. Cheung
,
Mariet Mathew Stephen
,
B Osborne
,
Christopher J.D. Wallis
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.5489/cuaj.9110
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.5489/cuaj.9110
Introduction: Approximately three-quarters of patients newly diagnosed with bladder cancer have non-muscle-invasive disease (NMIBC). Among these patients, those with high-risk (HR) features should be managed more aggressively in an attempt to circumvent the elevated risk of recurrence/progression. Population-based data on the incidence of HR-NMIBC and receipt of guideline-recommended care are limited. Methods: This retrospective, observational study gathered data from multiple linked provincial (Alberta) healthcare databases to describe baseline characteristics, treatment patterns, and survival outcomes in a population of individuals diagnosed with HR-NMIBC from 2010-2020. Data for all patients aged >18 years with T1, Tis, or high-grade Ta NMIBC (“high-risk”) were analyzed using basic statistics, multivariate regression analyses and the Kaplan-Meier method. Results: Of 6837 de novo NMIBC patients identified, 3874 (57%) were categorized as HR-NMIBC. The majority (82%) were male, with a median age of 72 years, and approximately half had a Charlson comorbidity index score ≥1. Following initial transurethral resection of bladder tumor (TURBT), 61% of the cohort received no adjuvant bacillus Calmette-Guérin (BCG) or chemotherapy, while 36% received BCG, 3% gemcitabine, and 1% mitomycin C. Patients underwent a median of four TURBT procedures. ‘Adequate BCG’ (≥5 induction doses + ≥2 maintenance doses) was received by 32% of BCG-treated and 12% of all HR-NMIBC patients. Survival was improved in patients receiving adequate BCG. Conclusions: Data from this large, real-world population highlights poor use of induction/maintenance BCG therapy following TURBT among patients with HR-NMIBC.
Related Topics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.5489/cuaj.9110
- https://cuaj.ca/index.php/journal/article/download/9110/6485
- OA Status
- diamond
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4412176223
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4412176223Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.5489/cuaj.9110Digital Object Identifier
- Title
-
A population-based analysis of patterns of care in patients with high-risk non-muscle-invasive bladder cancer from Alberta, CanadaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-07-08Full publication date if available
- Authors
-
Geoffrey Gotto, Nimira Alimohamed, Girish S. Kulkarni, Peter C. Black, Wassim Kassouf, Andrea Kokorovic, Bernhard J. Eigl, Normand Blais, Aly‐Khan A. Lalani, Winson Y. Cheung, Mariet Mathew Stephen, B Osborne, Christopher J.D. WallisList of authors in order
- Landing page
-
https://doi.org/10.5489/cuaj.9110Publisher landing page
- PDF URL
-
https://cuaj.ca/index.php/journal/article/download/9110/6485Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://cuaj.ca/index.php/journal/article/download/9110/6485Direct OA link when available
- Concepts
-
Bladder cancer, Medicine, Population, Cancer, Oncology, Internal medicine, Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4412176223 |
|---|---|
| doi | https://doi.org/10.5489/cuaj.9110 |
| ids.doi | https://doi.org/10.5489/cuaj.9110 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40637628 |
| ids.openalex | https://openalex.org/W4412176223 |
| fwci | 0.0 |
| type | article |
| title | A population-based analysis of patterns of care in patients with high-risk non-muscle-invasive bladder cancer from Alberta, Canada |
| biblio.issue | 10 |
| biblio.volume | 19 |
| biblio.last_page | 310 |
| biblio.first_page | 302 |
| topics[0].id | https://openalex.org/T10458 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9983999729156494 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2746 |
| topics[0].subfield.display_name | Surgery |
| topics[0].display_name | Bladder and Urothelial Cancer Treatments |
| topics[1].id | https://openalex.org/T10552 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9269000291824341 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Colorectal Cancer Screening and Detection |
| topics[2].id | https://openalex.org/T11411 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9103000164031982 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2734 |
| topics[2].subfield.display_name | Pathology and Forensic Medicine |
| topics[2].display_name | Tea Polyphenols and Effects |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780352672 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7845461368560791 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q504775 |
| concepts[0].display_name | Bladder cancer |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.5855152606964111 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2908647359 |
| concepts[2].level | 2 |
| concepts[2].score | 0.44379767775535583 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[2].display_name | Population |
| concepts[3].id | https://openalex.org/C121608353 |
| concepts[3].level | 2 |
| concepts[3].score | 0.41520148515701294 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[3].display_name | Cancer |
| concepts[4].id | https://openalex.org/C143998085 |
| concepts[4].level | 1 |
| concepts[4].score | 0.41405409574508667 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[4].display_name | Oncology |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.34627270698547363 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C99454951 |
| concepts[6].level | 1 |
| concepts[6].score | 0.14548593759536743 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[6].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/bladder-cancer |
| keywords[0].score | 0.7845461368560791 |
| keywords[0].display_name | Bladder cancer |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.5855152606964111 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/population |
| keywords[2].score | 0.44379767775535583 |
| keywords[2].display_name | Population |
| keywords[3].id | https://openalex.org/keywords/cancer |
| keywords[3].score | 0.41520148515701294 |
| keywords[3].display_name | Cancer |
| keywords[4].id | https://openalex.org/keywords/oncology |
| keywords[4].score | 0.41405409574508667 |
| keywords[4].display_name | Oncology |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.34627270698547363 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/environmental-health |
| keywords[6].score | 0.14548593759536743 |
| keywords[6].display_name | Environmental health |
| language | en |
| locations[0].id | doi:10.5489/cuaj.9110 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210173140 |
| locations[0].source.issn | 1911-6470, 1920-1214 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1911-6470 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Canadian Urological Association Journal |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | |
| locations[0].pdf_url | https://cuaj.ca/index.php/journal/article/download/9110/6485 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Canadian Urological Association Journal |
| locations[0].landing_page_url | https://doi.org/10.5489/cuaj.9110 |
| locations[1].id | pmid:40637628 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Canadian Urological Association journal = Journal de l'Association des urologues du Canada |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40637628 |
| locations[2].id | pmh:oai:europepmc.org:11325069 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12517452 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5086687064 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6637-2032 |
| authorships[0].author.display_name | Geoffrey Gotto |
| authorships[0].countries | CA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I168635309 |
| authorships[0].affiliations[0].raw_affiliation_string | Departments of Surgery and Oncology, University of Calgary, Calgary, AB, Canada. |
| authorships[0].institutions[0].id | https://openalex.org/I168635309 |
| authorships[0].institutions[0].ror | https://ror.org/03yjb2x39 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I168635309 |
| authorships[0].institutions[0].country_code | CA |
| authorships[0].institutions[0].display_name | University of Calgary |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Geoffrey Gotto |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Departments of Surgery and Oncology, University of Calgary, Calgary, AB, Canada. |
| authorships[1].author.id | https://openalex.org/A5006767981 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2930-4206 |
| authorships[1].author.display_name | Nimira Alimohamed |
| authorships[1].countries | CA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I168635309 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Medical Oncology, Department of Medicine, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada. |
| authorships[1].institutions[0].id | https://openalex.org/I168635309 |
| authorships[1].institutions[0].ror | https://ror.org/03yjb2x39 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I168635309 |
| authorships[1].institutions[0].country_code | CA |
| authorships[1].institutions[0].display_name | University of Calgary |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Nimira S Alimohamed |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Medical Oncology, Department of Medicine, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada. |
| authorships[2].author.id | https://openalex.org/A5018908850 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-6929-6124 |
| authorships[2].author.display_name | Girish S. Kulkarni |
| authorships[2].countries | CA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1325899441, https://openalex.org/I185261750 |
| authorships[2].affiliations[0].raw_affiliation_string | Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada. |
| authorships[2].institutions[0].id | https://openalex.org/I1325899441 |
| authorships[2].institutions[0].ror | https://ror.org/042xt5161 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I1325899441 |
| authorships[2].institutions[0].country_code | CA |
| authorships[2].institutions[0].display_name | University Health Network |
| authorships[2].institutions[1].id | https://openalex.org/I185261750 |
| authorships[2].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[2].institutions[1].country_code | CA |
| authorships[2].institutions[1].display_name | University of Toronto |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Girish S Kulkarni |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada. |
| authorships[3].author.id | https://openalex.org/A5050196540 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2919-7068 |
| authorships[3].author.display_name | Peter C. Black |
| authorships[3].countries | CA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I141945490 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. |
| authorships[3].institutions[0].id | https://openalex.org/I141945490 |
| authorships[3].institutions[0].ror | https://ror.org/03rmrcq20 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I141945490, https://openalex.org/I4210128534, https://openalex.org/I4210135497, https://openalex.org/I4387154919 |
| authorships[3].institutions[0].country_code | CA |
| authorships[3].institutions[0].display_name | University of British Columbia |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Peter C Black |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. |
| authorships[4].author.id | https://openalex.org/A5023126884 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8350-0531 |
| authorships[4].author.display_name | Wassim Kassouf |
| authorships[4].countries | CA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2801766832 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Urology, Department of Surgery, McGill University Health Center, Montreal, QC, Canada. |
| authorships[4].institutions[0].id | https://openalex.org/I2801766832 |
| authorships[4].institutions[0].ror | https://ror.org/04cpxjv19 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2801766832 |
| authorships[4].institutions[0].country_code | CA |
| authorships[4].institutions[0].display_name | McGill University Health Centre |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Wassim Kassouf |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Division of Urology, Department of Surgery, McGill University Health Center, Montreal, QC, Canada. |
| authorships[5].author.id | https://openalex.org/A5035012115 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-1957-7999 |
| authorships[5].author.display_name | Andrea Kokorovic |
| authorships[5].countries | CA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I129902397 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Urology, Dalhousie University, Halifax, NS, Canada. |
| authorships[5].institutions[0].id | https://openalex.org/I129902397 |
| authorships[5].institutions[0].ror | https://ror.org/01e6qks80 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I129902397 |
| authorships[5].institutions[0].country_code | CA |
| authorships[5].institutions[0].display_name | Dalhousie University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Andrea Kokorovic |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Urology, Dalhousie University, Halifax, NS, Canada. |
| authorships[6].author.id | https://openalex.org/A5089306688 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-1653-6929 |
| authorships[6].author.display_name | Bernhard J. Eigl |
| authorships[6].affiliations[0].raw_affiliation_string | BC Cancer, Vancouver, BC, Canada. |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Bernhard J Eigl |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | BC Cancer, Vancouver, BC, Canada. |
| authorships[7].author.id | https://openalex.org/A5018835840 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2698-4362 |
| authorships[7].author.display_name | Normand Blais |
| authorships[7].countries | CA |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210142730 |
| authorships[7].affiliations[0].raw_affiliation_string | Division of Medical Oncology and Hematology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. |
| authorships[7].institutions[0].id | https://openalex.org/I4210142730 |
| authorships[7].institutions[0].ror | https://ror.org/0410a8y51 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210142730 |
| authorships[7].institutions[0].country_code | CA |
| authorships[7].institutions[0].display_name | Centre Hospitalier de l’Université de Montréal |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Normand Blais |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Division of Medical Oncology and Hematology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. |
| authorships[8].author.id | https://openalex.org/A5034541004 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-9907-9112 |
| authorships[8].author.display_name | Aly‐Khan A. Lalani |
| authorships[8].countries | CA |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2799698466, https://openalex.org/I98251732 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada. |
| authorships[8].institutions[0].id | https://openalex.org/I2799698466 |
| authorships[8].institutions[0].ror | https://ror.org/02cwjh447 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I2799698466, https://openalex.org/I76442945 |
| authorships[8].institutions[0].country_code | CA |
| authorships[8].institutions[0].display_name | Juravinski Cancer Centre |
| authorships[8].institutions[1].id | https://openalex.org/I98251732 |
| authorships[8].institutions[1].ror | https://ror.org/02fa3aq29 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I98251732 |
| authorships[8].institutions[1].country_code | CA |
| authorships[8].institutions[1].display_name | McMaster University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Aly-Khan A Lalani |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada. |
| authorships[9].author.id | https://openalex.org/A5039850848 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-3679-4290 |
| authorships[9].author.display_name | Winson Y. Cheung |
| authorships[9].countries | CA |
| authorships[9].affiliations[0].raw_affiliation_string | Oncology Outcomes, Calgary, AB, Canada. |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I168635309 |
| authorships[9].affiliations[1].raw_affiliation_string | Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. |
| authorships[9].institutions[0].id | https://openalex.org/I168635309 |
| authorships[9].institutions[0].ror | https://ror.org/03yjb2x39 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I168635309 |
| authorships[9].institutions[0].country_code | CA |
| authorships[9].institutions[0].display_name | University of Calgary |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Winson Y Cheung |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Oncology Outcomes, Calgary, AB, Canada. |
| authorships[10].author.id | https://openalex.org/A5002057303 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Mariet Mathew Stephen |
| authorships[10].countries | CA |
| authorships[10].affiliations[0].raw_affiliation_string | Oncology Outcomes, Calgary, AB, Canada. |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I168635309 |
| authorships[10].affiliations[1].raw_affiliation_string | Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada. |
| authorships[10].institutions[0].id | https://openalex.org/I168635309 |
| authorships[10].institutions[0].ror | https://ror.org/03yjb2x39 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I168635309 |
| authorships[10].institutions[0].country_code | CA |
| authorships[10].institutions[0].display_name | University of Calgary |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Mariet Stephen |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Oncology Outcomes, Calgary, AB, Canada. |
| authorships[11].author.id | https://openalex.org/A5108351877 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | B Osborne |
| authorships[11].affiliations[0].raw_affiliation_string | Janssen Inc., Toronto, ON, Canada. |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Brendan J W Osborne |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Janssen Inc., Toronto, ON, Canada. |
| authorships[12].author.id | https://openalex.org/A5090167552 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-5990-4026 |
| authorships[12].author.display_name | Christopher J.D. Wallis |
| authorships[12].countries | CA |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I1291836623, https://openalex.org/I185261750 |
| authorships[12].affiliations[0].raw_affiliation_string | Urologic Oncology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. |
| authorships[12].institutions[0].id | https://openalex.org/I1291836623 |
| authorships[12].institutions[0].ror | https://ror.org/05deks119 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I1291836623, https://openalex.org/I4210130843 |
| authorships[12].institutions[0].country_code | CA |
| authorships[12].institutions[0].display_name | Mount Sinai Hospital |
| authorships[12].institutions[1].id | https://openalex.org/I185261750 |
| authorships[12].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[12].institutions[1].type | education |
| authorships[12].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[12].institutions[1].country_code | CA |
| authorships[12].institutions[1].display_name | University of Toronto |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | Christopher J D Wallis |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Urologic Oncology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://cuaj.ca/index.php/journal/article/download/9110/6485 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | A population-based analysis of patterns of care in patients with high-risk non-muscle-invasive bladder cancer from Alberta, Canada |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10458 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9983999729156494 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2746 |
| primary_topic.subfield.display_name | Surgery |
| primary_topic.display_name | Bladder and Urothelial Cancer Treatments |
| related_works | https://openalex.org/W1966504330, https://openalex.org/W1979139803, https://openalex.org/W2037631372, https://openalex.org/W4252436151, https://openalex.org/W2030889776, https://openalex.org/W2159000141, https://openalex.org/W1978297557, https://openalex.org/W1974041167, https://openalex.org/W2391409986, https://openalex.org/W1966775726 |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.5489/cuaj.9110 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210173140 |
| best_oa_location.source.issn | 1911-6470, 1920-1214 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1911-6470 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Canadian Urological Association Journal |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://cuaj.ca/index.php/journal/article/download/9110/6485 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Canadian Urological Association Journal |
| best_oa_location.landing_page_url | https://doi.org/10.5489/cuaj.9110 |
| primary_location.id | doi:10.5489/cuaj.9110 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210173140 |
| primary_location.source.issn | 1911-6470, 1920-1214 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1911-6470 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Canadian Urological Association Journal |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | |
| primary_location.pdf_url | https://cuaj.ca/index.php/journal/article/download/9110/6485 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Canadian Urological Association Journal |
| primary_location.landing_page_url | https://doi.org/10.5489/cuaj.9110 |
| publication_date | 2025-07-08 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.+ | 190 |
| abstract_inverted_index.a | 75, 131, 141, 179 |
| abstract_inverted_index.1% | 174 |
| abstract_inverted_index.3% | 171 |
| abstract_inverted_index.72 | 135 |
| abstract_inverted_index.C. | 176 |
| abstract_inverted_index.Of | 112 |
| abstract_inverted_index.Ta | 96 |
| abstract_inverted_index.an | 28 |
| abstract_inverted_index.as | 123 |
| abstract_inverted_index.be | 23 |
| abstract_inverted_index.by | 196 |
| abstract_inverted_index.de | 114 |
| abstract_inverted_index.in | 27, 74, 209 |
| abstract_inverted_index.no | 160 |
| abstract_inverted_index.of | 3, 35, 42, 46, 77, 134, 151, 156, 181, 198, 202, 224 |
| abstract_inverted_index.on | 39 |
| abstract_inverted_index.or | 94, 165 |
| abstract_inverted_index.to | 30, 65 |
| abstract_inverted_index.12% | 201 |
| abstract_inverted_index.32% | 197 |
| abstract_inverted_index.36% | 168 |
| abstract_inverted_index.61% | 155 |
| abstract_inverted_index.BCG | 226 |
| abstract_inverted_index.T1, | 92 |
| abstract_inverted_index.The | 125 |
| abstract_inverted_index.age | 133 |
| abstract_inverted_index.all | 86, 203 |
| abstract_inverted_index.and | 44, 71, 107, 137, 173, 200 |
| abstract_inverted_index.are | 49 |
| abstract_inverted_index.for | 85 |
| abstract_inverted_index.had | 140 |
| abstract_inverted_index.the | 32, 40, 108, 157 |
| abstract_inverted_index.use | 223 |
| abstract_inverted_index.was | 194, 207 |
| abstract_inverted_index.(HR) | 20 |
| abstract_inverted_index.3874 | 119 |
| abstract_inverted_index.6837 | 113 |
| abstract_inverted_index.BCG, | 170 |
| abstract_inverted_index.BCG. | 213 |
| abstract_inverted_index.Data | 84, 215 |
| abstract_inverted_index.This | 52 |
| abstract_inverted_index.Tis, | 93 |
| abstract_inverted_index.aged | 88 |
| abstract_inverted_index.care | 48 |
| abstract_inverted_index.data | 38, 57 |
| abstract_inverted_index.four | 182 |
| abstract_inverted_index.from | 58, 82, 216 |
| abstract_inverted_index.half | 139 |
| abstract_inverted_index.have | 10 |
| abstract_inverted_index.more | 25 |
| abstract_inverted_index.novo | 115 |
| abstract_inverted_index.poor | 222 |
| abstract_inverted_index.risk | 34 |
| abstract_inverted_index.this | 217 |
| abstract_inverted_index.were | 99, 121, 128 |
| abstract_inverted_index.with | 7, 18, 80, 91, 130, 232 |
| abstract_inverted_index.≥2 | 191 |
| abstract_inverted_index.(57%) | 120 |
| abstract_inverted_index.(82%) | 127 |
| abstract_inverted_index.(BCG) | 164 |
| abstract_inverted_index.(≥5 | 187 |
| abstract_inverted_index.Among | 14 |
| abstract_inverted_index.NMIBC | 97, 116 |
| abstract_inverted_index.TURBT | 183, 229 |
| abstract_inverted_index.among | 230 |
| abstract_inverted_index.basic | 102 |
| abstract_inverted_index.doses | 189 |
| abstract_inverted_index.index | 144 |
| abstract_inverted_index.male, | 129 |
| abstract_inverted_index.newly | 5 |
| abstract_inverted_index.score | 145 |
| abstract_inverted_index.study | 55 |
| abstract_inverted_index.these | 15 |
| abstract_inverted_index.those | 17 |
| abstract_inverted_index.tumor | 153 |
| abstract_inverted_index.using | 101 |
| abstract_inverted_index.while | 167 |
| abstract_inverted_index.years | 90 |
| abstract_inverted_index.≥1. | 146 |
| abstract_inverted_index.>18 | 89 |
| abstract_inverted_index.BCG’ | 186 |
| abstract_inverted_index.cancer | 9 |
| abstract_inverted_index.cohort | 158 |
| abstract_inverted_index.doses) | 193 |
| abstract_inverted_index.large, | 218 |
| abstract_inverted_index.linked | 60 |
| abstract_inverted_index.median | 132, 180 |
| abstract_inverted_index.should | 22 |
| abstract_inverted_index.years, | 136 |
| abstract_inverted_index.attempt | 29 |
| abstract_inverted_index.bladder | 8, 152 |
| abstract_inverted_index.disease | 12 |
| abstract_inverted_index.initial | 148 |
| abstract_inverted_index.managed | 24 |
| abstract_inverted_index.method. | 110 |
| abstract_inverted_index.receipt | 45 |
| abstract_inverted_index.therapy | 227 |
| abstract_inverted_index.(NMIBC). | 13 |
| abstract_inverted_index.(TURBT), | 154 |
| abstract_inverted_index.Charlson | 142 |
| abstract_inverted_index.HR-NMIBC | 43, 81, 204 |
| abstract_inverted_index.Methods: | 51 |
| abstract_inverted_index.Patients | 177 |
| abstract_inverted_index.Results: | 111 |
| abstract_inverted_index.Survival | 206 |
| abstract_inverted_index.adequate | 212 |
| abstract_inverted_index.adjuvant | 161 |
| abstract_inverted_index.analyses | 106 |
| abstract_inverted_index.analyzed | 100 |
| abstract_inverted_index.bacillus | 162 |
| abstract_inverted_index.baseline | 67 |
| abstract_inverted_index.describe | 66 |
| abstract_inverted_index.elevated | 33 |
| abstract_inverted_index.features | 21 |
| abstract_inverted_index.gathered | 56 |
| abstract_inverted_index.improved | 208 |
| abstract_inverted_index.limited. | 50 |
| abstract_inverted_index.majority | 126 |
| abstract_inverted_index.multiple | 59 |
| abstract_inverted_index.outcomes | 73 |
| abstract_inverted_index.patients | 4, 87, 117, 210, 231 |
| abstract_inverted_index.received | 159, 169, 195 |
| abstract_inverted_index.survival | 72 |
| abstract_inverted_index.(Alberta) | 62 |
| abstract_inverted_index.Following | 147 |
| abstract_inverted_index.HR-NMIBC. | 124, 233 |
| abstract_inverted_index.databases | 64 |
| abstract_inverted_index.diagnosed | 6, 79 |
| abstract_inverted_index.following | 228 |
| abstract_inverted_index.high-risk | 19 |
| abstract_inverted_index.incidence | 41 |
| abstract_inverted_index.induction | 188 |
| abstract_inverted_index.mitomycin | 175 |
| abstract_inverted_index.patients, | 16 |
| abstract_inverted_index.patients. | 205 |
| abstract_inverted_index.patterns, | 70 |
| abstract_inverted_index.receiving | 211 |
| abstract_inverted_index.resection | 150 |
| abstract_inverted_index.treatment | 69 |
| abstract_inverted_index.underwent | 178 |
| abstract_inverted_index.2010-2020. | 83 |
| abstract_inverted_index.circumvent | 31 |
| abstract_inverted_index.healthcare | 63 |
| abstract_inverted_index.high-grade | 95 |
| abstract_inverted_index.highlights | 221 |
| abstract_inverted_index.population | 76, 220 |
| abstract_inverted_index.provincial | 61 |
| abstract_inverted_index.real-world | 219 |
| abstract_inverted_index.regression | 105 |
| abstract_inverted_index.BCG-treated | 199 |
| abstract_inverted_index.categorized | 122 |
| abstract_inverted_index.comorbidity | 143 |
| abstract_inverted_index.identified, | 118 |
| abstract_inverted_index.individuals | 78 |
| abstract_inverted_index.maintenance | 192 |
| abstract_inverted_index.procedures. | 184 |
| abstract_inverted_index.statistics, | 103 |
| abstract_inverted_index.‘Adequate | 185 |
| abstract_inverted_index.Conclusions: | 214 |
| abstract_inverted_index.Kaplan-Meier | 109 |
| abstract_inverted_index.aggressively | 26 |
| abstract_inverted_index.gemcitabine, | 172 |
| abstract_inverted_index.multivariate | 104 |
| abstract_inverted_index.Approximately | 1 |
| abstract_inverted_index.Introduction: | 0 |
| abstract_inverted_index.approximately | 138 |
| abstract_inverted_index.chemotherapy, | 166 |
| abstract_inverted_index.observational | 54 |
| abstract_inverted_index.transurethral | 149 |
| abstract_inverted_index.retrospective, | 53 |
| abstract_inverted_index.three-quarters | 2 |
| abstract_inverted_index.Calmette-Guérin | 163 |
| abstract_inverted_index.Population-based | 37 |
| abstract_inverted_index.characteristics, | 68 |
| abstract_inverted_index.(“high-risk”) | 98 |
| abstract_inverted_index.non-muscle-invasive | 11 |
| abstract_inverted_index.guideline-recommended | 47 |
| abstract_inverted_index.induction/maintenance | 225 |
| abstract_inverted_index.recurrence/progression. | 36 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 13 |
| citation_normalized_percentile.value | 0.43424842 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |